Identification of a soluble OX40 isoform: Development of a specific and quantitative immunoassay

Journal of Immunological Methods

Volumn 255, Issue 1-2, 2001, Pages 67-72

  Taylor, Liz ^a   Schwarz, Herbert ^a  

^a Cantab Pharmaceuticals Ltd   (United Kingdom)

Author keywords

CLL; ELISA; OX40; Serum; Soluble; Stability

Indexed keywords

OX40 PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; BLOOD STORAGE; CANCER; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FREEZING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SOLUBILITY; TEMPERATURE; THAWING;

ANTIGENS, CD27; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; RECEPTORS, OX40; RECEPTORS, TUMOR NECROSIS FACTOR; SOLUBILITY;

EID: 0035452540     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(01)00424-0     Document Type: Article

References (18)

1. Urinary TNF-binding protein TNF soluble receptor protects mice against the lethal effect of TNF and endotoxic shock
2. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing
3. Fas/Apo-1 CD95 receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis
4. Protection from Fas mediated-apoptosis by a soluble form of the Fas molecule
5. Identification of a human OX-40 ligand, a costimulator of CD4+T cells with homology to tumor necrosis factor
6. Tumor necrosis factor receptor family members in the immune system
7. Regulation of T cell activity in vitro and in vivo by targeting the OX40-OX40 ligand interaction: Amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand fusion protein
8. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor
9. The TNF and TNF receptor superfamilies. Integrating mammalian biology
10. A soluble form of CD137 (ILA/4-1BB), a member of the TNF receptor family, is released by activated lymphocytes and is detectable in sera of patients with rheumatoid arthritis
11. Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin's disease: Relationship with disease activity and clinical stage
12. High serum level of the soluble form of CD30 molecule in the early phase of HIV infection as an independent predictor for progression to AIDS
13. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
14. OX-40: Life beyond the effector T cell stage
15. Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis
16. Engagement of the OX-40 receptor in vivo enhances antitumor immunity
17. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate
18. Successful therapy of collagen-induced arthritis with TNF receptor-IgG fusion protein and combination with anti-CD4